1. Home
  2. STKL vs STOK Comparison

STKL vs STOK Comparison

Compare STKL & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKL
  • STOK
  • Stock Information
  • Founded
  • STKL 1973
  • STOK 2014
  • Country
  • STKL United States
  • STOK United States
  • Employees
  • STKL N/A
  • STOK N/A
  • Industry
  • STKL Precious Metals
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKL Basic Materials
  • STOK Health Care
  • Exchange
  • STKL Nasdaq
  • STOK Nasdaq
  • Market Cap
  • STKL 771.1M
  • STOK 740.9M
  • IPO Year
  • STKL N/A
  • STOK 2019
  • Fundamental
  • Price
  • STKL $6.10
  • STOK $12.86
  • Analyst Decision
  • STKL Strong Buy
  • STOK Strong Buy
  • Analyst Count
  • STKL 2
  • STOK 5
  • Target Price
  • STKL $9.50
  • STOK $27.75
  • AVG Volume (30 Days)
  • STKL 764.5K
  • STOK 759.9K
  • Earning Date
  • STKL 08-06-2025
  • STOK 08-06-2025
  • Dividend Yield
  • STKL N/A
  • STOK N/A
  • EPS Growth
  • STKL N/A
  • STOK N/A
  • EPS
  • STKL N/A
  • STOK 0.88
  • Revenue
  • STKL $740,934,000.00
  • STOK $190,908,000.00
  • Revenue This Year
  • STKL $10.78
  • STOK $378.84
  • Revenue Next Year
  • STKL $8.39
  • STOK N/A
  • P/E Ratio
  • STKL N/A
  • STOK $14.28
  • Revenue Growth
  • STKL 12.92
  • STOK 2333.81
  • 52 Week Low
  • STKL $3.65
  • STOK $5.35
  • 52 Week High
  • STKL $8.11
  • STOK $16.15
  • Technical
  • Relative Strength Index (RSI)
  • STKL 52.61
  • STOK 52.47
  • Support Level
  • STKL $6.18
  • STOK $12.55
  • Resistance Level
  • STKL $6.68
  • STOK $14.99
  • Average True Range (ATR)
  • STKL 0.25
  • STOK 0.84
  • MACD
  • STKL -0.02
  • STOK -0.02
  • Stochastic Oscillator
  • STKL 43.40
  • STOK 25.18

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: